Collaborations

Dr Mathew Garnett
Mesobank is collaborating with the Wellcome Sanger Institute Garnett lab on the development and genomic characterisation of pleural mesothelioma organoid models.  This work is funded through a project grant from Asthma and Lung UK (formerly the British Lung Foundation).
https://www.sanger.ac.uk/group/garnett-group/

Professors William Cookson and Miriam Moffatt, Imperial College London
Mesobank is a major supporter of the National Mesothelioma Research Centre (NMRC) at Imperial College supplying mesothelioma samples for the NMRC genomic research programme.
https://www.imperial.ac.uk/national-centre-mesothelioma-research/

Professor George Malliaras, University of Cambridge
We are working with a consortium led by Professor Malliaras to study novel drug delivery methods in three hard-to-treat cancers, one of which is mesothelioma.  The programme is funded by the Engineering and Physical Sciences Research Council.
https://gtr.ukri.org/projects?ref=EP%2FS009000%2F1

Professor Kevin Blyth, University of Glasgow
Professor Blyth is leading the PREDICT-Meso study (PRE-malignant Drivers Combined with Target-Drug validation in Mesothelioma) funded through CRUK’s Accelerator scheme together with the Fondazione AIRC and the Fundación Científica de la Asociación Española Contra el Cáncer for a period of 5 years. The research programme aims to close the gap on identifying key molecular events in the early stages of disease by focussing on understanding how asbestos-driven inflammation develops into MPM.  Mesobank will be supplying paired pre-malignant benign pleural tissue and subsequent mesothelioma samples.
https://www.predictmeso.com/

Professor Judy Coulson, University of Liverpool
Through a NC3R grant (National Centre for the Replacement, Reduction and Refinement of animals in research), Professor Coulson is developing a chick embryo model to aid in the development of personalised therapies for mesothelioma.  Mesobank is supplying mesothelioma tissue for this programme of research.
https://www.liverpool.ac.uk/systems-molecular-and-integrative-biology/staff/judy-coulson/

Dr Luke Wylie
Dr Wylie, who is based at the Wellcome Trust Sanger Institute, is studying the mutational landscape of non-malignant pleura following asbestos exposure. This work is funded through a project grant from Asthma and Lung UK (formerly the British Lung Foundation).